Stock listing

HKEX:2196 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (復星醫藥) 股價

Hong Kong listing (HKEX) of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. · home listing Shanghai:600196

Follow Shanghai Fosun Pharmaceutical (Group) Co., Ltd. into a list and get an email when it puts out news.

Share price · HKEX:2196

$17.23 HKD +0.76 (+4.6%)

Close on Nov 5, 2026

Day range
$17.10 – $17.56 HKDNov 5, 2026
Volume
3.55M sharesNov 5, 2026
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Shanghai:600196 · Home¥23.66 CNY+0.39 (+1.7%)24,348,536¥23.29¥23.72¥23.23¥23.27Delayed 15+ min · 3:00 PM GMT+8, Nov 5, 2026
HKEX:2196$17.23 HKD+0.76 (+4.6%)3,549,066$17.20$17.56$17.10$16.47Close on Nov 5, 2026
OTC:SFOSF$2.14 USD-0.035 (-1.6%)1,000$2.14$2.14$2.14$2.175Close on Nov 5, 2026
Frankfurt:08HH€1.935 EUR+0.072 (+3.9%)—€1.935€1.935€1.935€1.863Close on Nov 5, 2026
Ticker
HKEX:2196
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
HKEX
Currency
HKD

What changed lately

Latest news

(600196)"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Indicative Announcement on Approval of a Controlled Subsidiary's Drug for Clinical Trials in Australia

Nov 5, 2026

(600196)"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Announcement on Progress of the Private Equity Investment Fund Established with the Company's Participation

Nov 5, 2026

(600196)"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Announcement on Progress of the Drug Clinical Trial of a Controlled Subsidiary

Nov 5, 2026

(600196)"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Announcement on Resignation of Senior Executive

Nov 3, 2026

(600196)"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Report for Q3 2026

Oct 28, 2026

(600196)"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Pre-announcement on the Q3 2026 Performance Briefing

Oct 28, 2026

(600196)"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Announcement on Release of Pledge of Certain Shares Held by Shareholder

Oct 27, 2026

(600196)"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Announcement on Progress in Providing Guarantees for Controlled Subsidiaries

Oct 17, 2026

(600196)"Shanghai Fosun Pharmaceutical (Group) Co., Ltd."Announcement on Results of Reserved Grant under the 2025 A-Share Stock Option Incentive Plan

Sep 29, 2026

A New International Medical Approach Aimed at Reversing Diabetes has Officially Launched in Shenzhen, China

Sep 28, 2026

All Shanghai Fosun Pharmaceutical (Group) Co., Ltd. news

Decks

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
76 in the last 12 months · 100 in all · newest Nov 5, 2026 · oldest 2022
Decks
4 decks · latest Oct 12, 2026

Where Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is listed

ListingExchangeCountryCurrency
Shanghai:600196 复星医药 · Home listingShanghaiChinaCNY
HKEX:2196 復星醫藥 · This pageHKEXHong KongHKD
OTC:SFOSFOTCUnited StatesUSD
LS Exchange:A1J68DLS ExchangeGermanyEUR
Lang & Schwarz:A1J68DLang & SchwarzGermanyEUR
gettex:08HHgettexGermanyEUR
Tradegate:08HHTradegateGermanyEUR
Dusseldorf:08HHDusseldorfGermanyEUR
Frankfurt:08HHFrankfurtGermanyEUR
Munich:08HHMunichGermanyEUR
Stuttgart:08HHStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Shanghai Fosun Pharmaceutical (Group) Co., Ltd.